Cure for HIV: New possibility on horizon

Journal of Pharmacy and Bioallied Sciences

Volumn 3, Issue 3, 2011, Pages 461-464

  Singh, Anchal Pratap ^a,b   Singh, Udai ^b   Varma, Ajit ^b   Verma, Ashish Swarup ^b  

^a A T STILL UNIVERSITY   (United States)

^b AMITY UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; HLA ANTIGEN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; GENE MUTATION; HEALTH SERVICE; HETEROZYGOSITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; LETTER; MACROPHAGE; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTIVITY;

EID: 80052752924     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.84468     Document Type: Letter

References (16)

1. Prescott WH. History of the conquest of Mexico and the history of the conquest of Peru. New York: Rowan and Littlefield; 2000.
2. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor account for resistance of some multiply exposed individual to HIV-1 infection. Cell 1996; 86:367-77. (Pubitemid 26272077)
3. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305:1425-31. (Pubitemid 12240076)
4. Verma AS, Singh A, Singh UP, Dwivedi PD. NeuroAIDS in Indian Scenario. In: Gaur RK, Sharma P, Pratap R, Sharma KP, Sharma M, Dwivedi R editors. Recent trends in biotechnology and microbiology. New York: Nova Science Publisher; 2010. p 155-167.
5. AIDS Info. Rockville, MD. [updated 2010, December 9] Available from: http://www.aidsinfo.nih.gov [Last accessed on 2010 Dec 9].
6. Markel H. The search for effective HIV vaccines. N Engl J Med 2003; 353:753-6.
7. Berger, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700. (Pubitemid 29241137)
8. Levy JA. HIV and the pathogenesis of AIDS. 3rd ed. Washington, DC: ASM Press; 2007.
9. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 1996; 2:412-7. (Pubitemid 26191912)
10. de Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, Broersen SM, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997; 127:882-90. (Pubitemid 27490625)
11. Shearer GM, Clerici M. Protective immunity against HIV infections: Has nature done experiment for us? Immunol Today. 1996; 17:21-4. (Pubitemid 26019253)
12. Hütter G, Nowak D, Mossner M, Ganepota S, Mubig A, Allers K, et al. Long-term control of HIV by CCR5 delta32/delta32 stem-cell transplantation. N Engl J Med 2009; 360:692-8.
13. Michael NL, Nelson JA, Kewal Ramani VN, Chang G, O'Brien SJ, Mascola JR, et al. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol 1998; 72:6040-7. (Pubitemid 28283393)
14. Cohen J. Building an HIV-proof immune system. Science 2007; 317:612-4.
15. An DS, Donahue RE, Kamata M, Poon B, Metzger M, Mao SH, et al. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci USA 2007; 104:13110-5.
16. Verma AS, Singh A. Bone Marrow Transplantation: A New Avenue to Cure HIV (e-Letter) Blood (bloodjournal.hematologylibrary.org/cgi/e-letters) Blood, 10 March 2011,117:10. Accessed March 8, 2011.